Docetaxel in the first- and second-line therapy of gastric cancer;Docetaxel in der first- und second-line-therapie des magenkarzinoms

Onkologie

Volumn 23, Issue SUPPL. 6, 2000, Pages 40-42

  Vanhoefer, U ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID;

CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; HUMAN; MONOTHERAPY; PHASE 2 CLINICAL TRIAL; STOMACH CANCER;

EID: 0033762689     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Surgical treatment of gastric cancer: Retrospective survey of 1,704 operated cases with special reference to total gastrectomy as the operation of choice
2. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
3. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
4. Weekly 24h-infusion of high dose FU (HD-FU) plus folinic acid (FA) plus biweekly cisplatin (C) (Group A) of HD-FU/FA/C plus epirubicin (E) (Group B) in locally advanced or metastatic gastric cancer
5. Docetaxel (TaxotereTM) in advanced gastric cancer: Results of a phase II clinical trial
6. Monotherapy with docetaxel and granulocyte colony-stimulating factor in advanced gastric cancer
7. Phase II trial of docetaxel (Taxotere) in patients with adenocarci-noma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of Protocol E1293
8. Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: A Japanese Cooperative Study Group trial (group A)
9. Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer
10. Taxotere-cispla-tin (TC) in advanced gastric carcinoma (AGC): An active drug combination
11. A phase II study of docetaxel (TXT) with weekly high-dose 5-FU & leucovorin (24-hour infusion) in advanced gastric cancer
12. 5FU in protracted continuous IV infusion (5FUpiv) can be added to Taxotere-cisplatin (TC) without dose-reduction of TC in advanced gastric carcinoma (AGC)
13. Phase II study of docetaxel as second line chemotherapy (CT) in metastatic gastric cancer
14. Schedule-dependent cytotoxic interactions of irinotecan (SN-38) and docetaxel in non-small-cell lung cancer